Table 2.
Tertile 1 | Tertile 2 | Tertile 3 | P trend b | P heterogeneity c | ||
---|---|---|---|---|---|---|
Overalld | Median of 25(OH)D, ng/mL | 19.0 | 27.9 | 37.4 | ||
No. of cases/controls (318/624) | 122/212 | 109/208 | 87/204 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.90 (0.65-1.23) | 0.69 (0.48-1.00) | 0.05 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.90 (0.64-1.25) | 0.71 (0.48-1.05) | 0.09 | ||
Intratumoural periglandular reaction | Absent | |||||
No. of cases/controls (41/79) | 14/27 | 16/25 | 11/27 | |||
Crude OR (95% CI)e | 1 [Referent] | 1.24 (0.52-2.96) | 0.72 (0.27-1.94) | 0.58 | <0.001 | |
Multivariable OR (95% CI)f | 1 [Referent] | 1.15 (0.47-2.85) | 0.71 (0.26-1.95) | 0.55 | 0.001 | |
Mild | ||||||
No. of cases/controls (230/451) | 85/165 | 79/154 | 66/132 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.99 (0.68-1.45) | 0.95 (0.62-1.45) | 0.81 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 1.00 (0.67-1.47) | 0.98 (0.62-1.54) | 0.93 | ||
High | ||||||
No. of cases/controls (47/94) | 23/20 | 14/29 | 10/45 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.33 (0.12-0.88) | 0.10 (0.03-0.35) | <0.001 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.33 (0.12-0.90) | 0.10 (0.03-0.35) | <0.001 | ||
Tumour-infiltrating lymphocytes | Absent | |||||
No. of cases/controls (223/434) | 83/158 | 80/142 | 60/134 | |||
Crude OR (95% CI)e | 1 [Referent] | 1.06 (0.73-1.55) | 0.80 (0.52-1.24) | 0.37 | 0.08 | |
Multivariable OR (95% CI)f | 1 [Referent] | 1.02 (0.69-1.51) | 0.81 (0.51-1.30) | 0.42 | 0.13 | |
Mild | ||||||
No. of cases/controls (64/128) | 25/40 | 24/45 | 15/43 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.80 (0.39-1.65) | 0.50 (0.22-1.17) | 0.11 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.91 (0.44-1.89) | 0.50 (0.21-1.20) | 0.13 | ||
High | ||||||
No. of cases/controls (31/62) | 14/12 | 8/21 | 9/29 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.31 (0.10-0.98) | 0.20 (0.05-0.73) | 0.02 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.33 (0.10-1.05) | 0.22 (0.06-0.87) | 0.03 | ||
Crohn's-like lymphoid reactiong | Absent | |||||
No. of cases/controls (189/369) | 72/140 | 66/112 | 51/117 | |||
Crude OR (95% CI)e | 1 [Referent] | 1.13 (0.75-1.70) | 0.81 (0.50-1.29) | 0.43 | 0.01 | |
Multivariable OR (95% CI)f | 1 [Referent] | 1.08 (0.71-1.66) | 0.81 (0.49-1.33) | 0.45 | 0.09 | |
Mild | ||||||
No. of cases/controls (54/107) | 21/30 | 18/38 | 15/39 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.64 (0.29-1.41) | 0.47 (0.19-1.18) | 0.11 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.72 (0.31-1.65) | 0.55 (0.20-1.49) | 0.24 | ||
High | ||||||
No. of cases/controls (16/32) | 8/5 | 7/12 | 1/15 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.37 (0.09-1.50) | 0.05 (0.00-0.50) | 0.008 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.56 (0.13-2.36) | 0.08 (0.01-0.86) | 0.03 | ||
Peritumoural lymphocytic reaction | Absent | |||||
No. of cases/controls (49/94) | 19/27 | 15/31 | 15/36 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.71 (0.31-1.67) | 0.53 (0.22-1.31) | 0.16 | 0.05 | |
Multivariable OR (95% CI)f | 1 [Referent] | 0.69 (0.28-1.68) | 0.55 (0.22-1.38) | 0.19 | 0.08 | |
Mild | ||||||
No. of cases/controls (201/396) | 74/149 | 74/139 | 53/108 | |||
Crude OR (95% CI)e | 1 [Referent] | 1.06 (0.71-1.58) | 0.98 (0.62-1.55) | 0.95 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 1.06 (0.70-1.59) | 0.98 (0.60-1.59) | 0.95 | ||
High | ||||||
No. of cases/controls (68/134) | 29/36 | 20/38 | 19/60 | |||
Crude OR (95% CI)e | 1 [Referent] | 0.66 (0.32-1.37) | 0.32 (0.14-0.73) | 0.006 | ||
Multivariable OR (95% CI)f | 1 [Referent] | 0.64 (0.30-1.36) | 0.34 (0.14-0.81) | 0.02 |
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; CI, confidence interval; OR, odds ratio.
Component of lymphocytic reaction was categorised as: absent, mild, and high (moderate or marked).
Test for trend was performed using the median value of each tertile of plasma 25-hydroxyvitamin D.
Global test comparing the risk of colorectal cancer associated with median value of each tertile of plasma 25-hydroxyvitamin D across subtypes of tumours.
Analysis was based on all cases having data on specific components of lymphocytic reaction and their matched controls.
Conditional logistic regression adjusted for the matching factors (sex, age and time of blood draw).
In addition to the matching factors, multivariable conditional logistic regression adjusted for family history of colorectal cancer, endoscopic screening, regular use of aspirin or non-steroidal anti-inflammatory drug, pack-years of smoking before age 30 years old (continuous), body mass index (continuous, kg/m2), physical activity (continuous, metabolic equivalent hour per week), alcohol consumption (continuous, g/day), and Dietary Approaches to Stop Hypertension score (continuous).
Fifty nine cases with missing data on Crohn's-like lymphoid reaction and the matched 116 controls were excluded.